Skip to main content
All lobbying filings

COALITION FOR HEALTHCARE COMMUNICATIONS

Lobbying for COALITION FOR HEALTHCARE COMMUNICATIONS · Healthcare Advertising, Communications, Publishing

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 2, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New York

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

S.483 (HR 1117) - Responsibility in Drugs Advertising Act S.229 - Drug Pricing Transparency for Consumers Act S.1785 (HR 3010) - No Handouts for Drug Advertising Act S.2068 (HR 4605) - End Prescription Drug Ads Now

 Bills named in this filing 7
  • S. 483
    Responsibility in Drug Advertising Act of 2025
  • H.R. 1117
    Responsibility in Drug Advertising Act of 2025
  • S. 229
    DTC Act of 2025
  • S. 1785
    No Handouts for Drug Advertisements Act
  • H.R. 3010
    No Handouts for Drug Advertisements Act
  • S. 2068
    End Prescription Drug Ads Now Act
  • H.R. 4605
    End Prescription Drug Ads Now Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem